Kashyap TeleMed.

  • Market Cap: Micro Cap
  • Industry: Computers - Software & Consulting
  • ISIN: INE108B01029
  • NSEID:
  • BSEID: 531960
INR
5.89
0.00 (0.00%)
BSENSE

Feb 09

BSE+NSE Vol: 6.51 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 679992,
    "name": "Kashyap TeleMed.",
    "stock_name": "Kashyap TeleMed.",
    "full_name": "Kashyap Tele-Medicines Ltd",
    "name_url": "stocks-analysis/kashyap-telemed",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "5.89",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "5.89",
    "mcapval": "28.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531960,
    "symbol": "",
    "ind_name": "Computers - Software & Consulting",
    "ind_code": 57,
    "indexname": "",
    "isin": "INE108B01029",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "6.51 k",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kashyap-telemed-679992-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Kashyap TeleMed.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-kashyap-telemed-3709199",
        "imagepath": "",
        "date": "2025-11-17 23:23:15",
        "description": "Answer:\nThe historical performance of Kashyap TeleMed shows a relatively stable but low level of net sales over the years, with figures remaining at 0.19 Cr in both Mar'25 and Mar'24, and slightly higher at 0.20 Cr in Mar'23, Mar'22, and Mar'19. The total operating income has mirrored the net sales, remaining at 0.19 Cr in Mar'25 and Mar'24, while also being 0.20 Cr in the previous years. The company has not incurred any raw material costs, purchase of finished goods, or power costs during this period. Employee costs have increased from 0.05 Cr in Mar'17 to 0.11 Cr in Mar'25, indicating a gradual rise in operational expenses. However, total expenditure (excluding depreciation) peaked at 0.30 Cr in Mar'22 before decreasing to 0.19 Cr in Mar'25. Operating profit has fluctuated, with a loss of 0.03 Cr in Mar'24 and a break-even point in Mar'25, while profit before tax has remained at 0.00 Cr in Mar'25 and Mar'..."
      }
    ],
    "total": 14,
    "sid": "679992",
    "stock_news_url": "https://www.marketsmojo.com/news/kashyap-tele-medicines-679992"
  },
  "announcements": [
    {
      "caption": "Un-Audited Financial Results (UFR) For The Third Quarter And Nine Months Ended December 31 2025 Along With The Statutory Auditors Limited Review Report",
      "datetime": "10-Feb-2026",
      "details": "Un-Audited Financial Results for the Third Quarter and Nine Months ended December 31 2025 along with the Statutory Auditors Limited review report",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Un-Audited Financial Results (UFR) For The Third Quarter And Nine Months Ended December 31 2025 Along With The Statutory Auditors Limited Review Report",
      "datetime": "10-Feb-2026",
      "details": "Un-Audited Financial Results (UFR) for the Third quarter and Nine months ended December 31 2025 along with the Statutory Auditors Limited Review Report",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "21-Jan-2026",
      "details": "Kashyap Tele-Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve Unaudited results for quarter ended December 31 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Un-Audited Financial Results (UFR) For The Third Quarter And Nine Months Ended December 31 2025 Along With The Statutory Auditors Limited Review Report

10-Feb-2026 | Source : BSE

Un-Audited Financial Results for the Third Quarter and Nine Months ended December 31 2025 along with the Statutory Auditors Limited review report

Board Meeting Outcome for Un-Audited Financial Results (UFR) For The Third Quarter And Nine Months Ended December 31 2025 Along With The Statutory Auditors Limited Review Report

10-Feb-2026 | Source : BSE

Un-Audited Financial Results (UFR) for the Third quarter and Nine months ended December 31 2025 along with the Statutory Auditors Limited Review Report

Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

21-Jan-2026 | Source : BSE

Kashyap Tele-Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve Unaudited results for quarter ended December 31 2025

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available